Skip to content

Continuous Versus 1-min Oscillometric Arterial BP Monitoring

Continuous Invasive Versus 1-min Interval Oscillometric Arterial Pressure Monitoring and Hypotension During Induction of Anesthesia: a Bicenter, Randomized, Noninferiority Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05792436
Enrollment
258
Registered
2023-03-31
Start date
2023-04-27
Completion date
2025-08-21
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, General

Keywords

Intraoperative hypotention, Induction of anesthesia, Arterial blood pressure monitoring

Brief summary

Hypotension is common during surgery and about one-third of hypotension occur during the period from anesthesia induction to skin incision. Therefore, monitoring blood pressure during this period is crucial. Two methods are used for measuring blood pressure during surgery: the intermittent measurement method (oscillometric method) and the continuous measurement method (arterial catheterization method). The latter is frequently used in surgical patients who require meticulous hemodynamic management, although there is no clearly defined indication for its use. Despite the benefits of arterial catheterization, it is often delayed after induction of general anesthesia, and blood pressure is monitored intermittently using the oscillometric method. A recent study showed that continuous arterial pressure monitoring using arterial catheterization method during the induction of general anesthesia reduced hypotension significantly compared to 2.5-min interval intermittent arterial pressure monitoring using oscillometric method. The study was conducted on patients scheduled for continuous arterial pressure monitoring during surgery and the group with continuous arterial pressure monitoring showed significantly lower incidence of hypotension during the first 15 minutes of anesthesia induction. However, measuring blood pressure using the oscillometric method at 1-min interval, rather than 2.5-min interval, may not be significantly inferior to continuous monitoring via arterial catheterization in terms of hypotension occurrence. This study aims to compare hypotension incidence between arterial catheterization method and oscillometric method with 1-min interval during induction of anesthesia in non-cardiac surgery patients.

Interventions

DEVICE1-min interval oscillometric method

Before induction of anesthesia, 20-gauge catheter is inserted to radial artery after local anesthesia with lidocaine, and continuous blood pressure monitoring is started. Anesthesia is induced using propofol, opioids (fentanyl or remifentanil), and neuromuscular relaxants (rocuronium, cisatracurium, or vecuronium). For maintenance of anesthesia, propofol infusion or inhalation anesthetics (sevoflurane or desflurane) are used. From the start of anesthesia induction to 15 minutes after, arterial blood pressure is monitored at 1-min interval using oscillometric method. The display of continuous arterial pressure on the anesthesia monitor is turned off during the 15-min study period.

DEVICEarterial catheterization method

During the same time window for 1-min interval oscillometric method, arterial blood pressure is monitored using continuous blood pressure monitoring.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients aged 19 or older undergoing scheduled non-cardiac surgery with general anesthesia and continuous invasive arterial blood pressure monitoring via the radial artery

Exclusion criteria

* Arterial access is clinically necessary before induction of anesthesia (e.g., moderate or higher degree of aortic stenosis, moderate or higher degree of heart failure, coronary artery disease requiring revascularization, intracranial aneurysm with a significant risk of rupture, etc.) * Emergency surgery * American Society of Anesthesiologists (ASA) physical status 5 or 6 * Arterial access is required in a different artery other than the radial artery (e.g., the femoral artery) * Electrocardiogram other than sinus rhythm * Refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
MAP integralFrom the start of anesthesia induction to 15 minutes afterThe area under the mean arterial pressure (MAP) of 65 mmHg calculated using the MAP recorded every second

Secondary

MeasureTime frameDescription
Area under MAP of 60, 50, 40 mmHg (mmHg∙min)From the start of anesthesia induction to 15 minutes aftercalculated using the MAP recorded every second
Duration of MAP <65, <60, <50, <40 mmHg (min)From the start of anesthesia induction to 15 minutes aftercalculated using the MAP recorded every second
Exposure to MAP <65, <60, <50, and <40 mmHg (binary)From the start of anesthesia induction to 15 minutes aftercalculated using the MAP recorded every second
Exposure to continuous MAP <65, <60, <50, <40 mmHg for 1 minute or longer (binary)From the start of anesthesia induction to 15 minutes aftercalculated using the MAP recorded every second
Area above MBP of 100, 110, 120, 140 mmHg (mmHg∙min)From the start of anesthesia induction to 15 minutes aftercalculated using the MAP recorded every second
MAP standard deviation (mmHg)From the start of anesthesia induction to 15 minutes aftercalculated using the MAP recorded every second
Use of vasopressor (binary)From the start of anesthesia induction to 15 minutes afterephedrine, phenylephrine, norepinephrine (binary)
Use of vasopressor (dose)From the start of anesthesia induction to 15 minutes afterephedrine (mg), phenylephrine (μg/kg), norepinephrine (μg/kg)
Crystalloid (ml)From the start of anesthesia induction to 15 minutes afterTotal amount of crystalloid administered

Countries

South Korea

Contacts

STUDY_DIRECTORKaram Nam, MD

Seoul National University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026